These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 34351000)

  • 41. Four-Year Follow-up of [
    Kogan RV; Janzen A; Meles SK; Sittig E; Renken RJ; Gurvits V; Mayer G; Leenders KL; Oertel WH;
    Mov Disord; 2021 Jan; 36(1):230-235. PubMed ID: 32909650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In Vivo Investigation of Glucose Metabolism in Idiopathic and PRKN-Related Parkinson's Disease.
    Borsche M; Märtens A; Hörmann P; Brückmann T; Lohmann K; Tunc S; Klein C; Hiller K; Balck A
    Mov Disord; 2023 Apr; 38(4):697-702. PubMed ID: 36717366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sphingosine-1-Phosphate, Motor Severity, and Progression in Parkinson's Disease (MARK-PD).
    Schwedhelm E; Englisch C; Niemann L; Lezius S; von Lucadou M; Marmann K; Böger R; Peine S; Daum G; Gerloff C; Choe CU
    Mov Disord; 2021 Sep; 36(9):2178-2182. PubMed ID: 34008894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
    Healy DG; Falchi M; O'Sullivan SS; Bonifati V; Durr A; Bressman S; Brice A; Aasly J; Zabetian CP; Goldwurm S; Ferreira JJ; Tolosa E; Kay DM; Klein C; Williams DR; Marras C; Lang AE; Wszolek ZK; Berciano J; Schapira AH; Lynch T; Bhatia KP; Gasser T; Lees AJ; Wood NW;
    Lancet Neurol; 2008 Jul; 7(7):583-90. PubMed ID: 18539534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal Changes in Parkinson's Disease Symptoms with and Without Rapid Eye Movement Sleep Behavior Disorder: The Oxford Discovery Cohort Study.
    Liu Y; Lawton MA; Lo C; Bowring F; Klein JC; Querejeta-Coma A; Scotton S; Welch J; Razzaque J; Barber T; Ben-Shlomo Y; Hu MT
    Mov Disord; 2021 Dec; 36(12):2821-2832. PubMed ID: 34448251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial aggregation of Parkinson's disease may affect progression of motor symptoms and dementia.
    Gaare JJ; Skeie GO; Tzoulis C; Larsen JP; Tysnes OB
    Mov Disord; 2017 Feb; 32(2):241-245. PubMed ID: 27862270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.
    Noyce AJ; R'Bibo L; Peress L; Bestwick JP; Adams-Carr KL; Mencacci NE; Hawkes CH; Masters JM; Wood N; Hardy J; Giovannoni G; Lees AJ; Schrag A
    Mov Disord; 2017 Feb; 32(2):219-226. PubMed ID: 28090684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mortality and morbidity after spinal surgery in patients with Parkinson's disease: a retrospective matched-pair cohort study.
    Oichi T; Chikuda H; Ohya J; Ohtomo R; Morita K; Matsui H; Fushimi K; Tanaka S; Yasunaga H
    Spine J; 2017 Apr; 17(4):531-537. PubMed ID: 27884743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-sectional survey of Parkinson's disease and parkinsonism in a rural area of the United Kingdom.
    Hobson P; Gallacher J; Meara J
    Mov Disord; 2005 Aug; 20(8):995-8. PubMed ID: 15852368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease.
    Mahlknecht P; Pechlaner R; Boesveldt S; Volc D; Pinter B; Reiter E; Müller C; Krismer F; Berendse HW; van Hilten JJ; Wuschitz A; Schimetta W; Högl B; Djamshidian A; Nocker M; Göbel G; Gasperi A; Kiechl S; Willeit J; Poewe W; Seppi K
    Mov Disord; 2016 Sep; 31(9):1408-13. PubMed ID: 27159493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased Risk of Parkinson's Disease in Patients With Schizophrenia Spectrum Disorders.
    Kuusimäki T; Al-Abdulrasul H; Kurki S; Hietala J; Hartikainen S; Koponen M; Tolppanen AM; Kaasinen V
    Mov Disord; 2021 Jun; 36(6):1353-1361. PubMed ID: 33405293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
    Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
    Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of statin use with Parkinson's disease: Dose-response relationship.
    Jeong SM; Jang W; Shin DW
    Mov Disord; 2019 Jul; 34(7):1014-1021. PubMed ID: 30938893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Supine sleep and obstructive sleep apnea syndrome in Parkinson's disease.
    Cochen De Cock V; Benard-Serre N; Driss V; Granier M; Charif M; Carlander B; Desplan M; Croisier Langenier M; Cugy D; Bayard S
    Sleep Med; 2015 Dec; 16(12):1497-501. PubMed ID: 26611947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
    Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
    BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Cause and Duration of Emergency Admissions to Hospital in People with Idiopathic Parkinson's Disease, Under the Care of a UK Service, During the First Year of the COVID-19 Pandemic.
    Ellis PK; Davies ML; Gray WK; Barber M; Bolnykh I; Sadler M; Walker RW
    J Parkinsons Dis; 2022; 12(6):1833-1840. PubMed ID: 35634853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Corneal Confocal Microscopy Identifies Parkinson's Disease with More Rapid Motor Progression.
    Lim SH; Ferdousi M; Kalteniece A; Mahfoud ZR; Petropoulos IN; Malik RA; Kobylecki C; Silverdale M
    Mov Disord; 2021 Aug; 36(8):1927-1934. PubMed ID: 33826165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mortality and causes of death in patients with Parkinson's disease: a nationwide population-based cohort study.
    Ryu DW; Han K; Cho AH
    Front Neurol; 2023; 14():1236296. PubMed ID: 37719757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.
    Goldman JG; Andrews H; Amara A; Naito A; Alcalay RN; Shaw LM; Taylor P; Xie T; Tuite P; Henchcliffe C; Hogarth P; Frank S; Saint-Hilaire MH; Frasier M; Arnedo V; Reimer AN; Sutherland M; Swanson-Fischer C; Gwinn K; ; Kang UJ
    Mov Disord; 2018 Feb; 33(2):282-288. PubMed ID: 29205509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
    Omer N; Giladi N; Gurevich T; Bar-Shira A; Gana-Weisz M; Glinka T; Goldstein O; Kestenbaum M; Cedarbaum JM; Mabrouk OS; Fraser KB; Shirvan JC; Orr-Urtreger A; Mirelman A; Thaler A
    Mov Disord; 2022 Jan; 37(1):190-195. PubMed ID: 34550621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.